Email updates

Keep up to date with the latest news and content from BMC Public Health and BioMed Central.

Open Access Research article

The potential effect of temporary immunity as a result of bias associated with healthy users and social determinants on observations of influenza vaccine effectiveness; could unmeasured confounding explain observed links between seasonal influenza vaccine and pandemic H1N1 infection?

Natasha S Crowcroft123* and Laura C Rosella12

Author Affiliations

1 Public Health Ontario, Toronto, Ontario, Canada, 480 University Avenue, Suite 300, Toronto, M5G 1 V2, ON, Canada

2 Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada

3 Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada

For all author emails, please log on.

BMC Public Health 2012, 12:458  doi:10.1186/1471-2458-12-458

The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1471-2458/12/458


Received:14 January 2012
Accepted:15 June 2012
Published:20 June 2012

© 2012 Crowcroft and Rosella; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

Five observational studies from Canada found an association between seasonal influenza vaccine receipt and increased risk of pandemic influenza H1N1 2009 infection. This association remains unexplained. Although uncontrolled confounding has been suggested as a possible explanation, the nature of such confounding has not been identified. Observational studies of influenza vaccination can be affected by confounding due to healthy users and the influence of social determinants on health. The purpose of this study was to investigate the influence that these two potential confounders may have in combination with temporary immunity, using stratified tables. The hypothesis is that respiratory virus infections may activate a temporary immunity that provides short-term non-specific protection against influenza and that the relationship with being a healthy user or having a social determinant may result in confounding.

Methods

We simulated the effect of confounding on vaccine effectiveness assuming that this could result from both social determinants and healthy user effects as they both influence the risk of seasonal influenza and non-influenza respiratory virus infections as well as the likelihood of being vaccinated. We then examined what impact this may have had on measurement of seasonal influenza vaccine effectiveness against pandemic influenza.

Results

In this simulation, failure to adjust for healthy users and social determinants would result in an erroneously increased risk of pandemic influenza infection associated with seasonal influenza vaccination. The effect sizes were not however large.

Conclusions

We found that unmeasured healthy user effects and social determinants could result in an apparent association between seasonal influenza vaccine and pandemic influenza infection by virtue of being related to temporary immunity. Adjustment for social determinants of health and the healthy user effects are required in order to improve the quality of observational studies of influenza vaccine effectiveness.

Keywords:
Influenza; Influenza vaccination; Confounding; Epidemiology

Background

Five observational studies carried out during the 2009 pandemic of influenza A H1N1 (pH1N1) in Canada found that previous 2008-9 seasonal influenza vaccine appeared to increase risk of being infected with the pandemic virus [1,2]. No significant methodological flaws were identified; unmeasured confounding was, however, the most common explanation for the observed association. Observational studies of seasonal influenza vaccination have been shown to be affected by confounding due to healthy-user effects and social determinants [3,4]. Such unmeasured confounding is unlikely to be the whole explanation given the prevalence and strength of association needed to explain the observations [5]. Heath Kelly and colleagues demonstrated a potential biological mechanism to explain the findings [6] in an elegant analysis. They postulated that a temporary cross-protective effect against pandemic influenza might have resulted from increased rates of seasonal influenza infection occurring in unvaccinated individuals in the months just prior to the start of the pandemic, when seasonal influenza was indeed circulating in Canada. They acknowledged however that the resulting effect sizes using realistic parameters were not large enough to explain what was observed in Canada. The idea of a temporary cross-protective effect is however consistent with no similar risk being reported by the same Canadian partnership in the second pandemic wave in Canada [7].

Cross-protection between influenza strains may have a number of mechanisms that could result in such a finding. Before carrying out expensive and invasive experiments to look for such biological effects it can be helpful to explore in simulations non-biological explanations. We carried out an exploration of how activation of a temporary cross-reactive immune response might explain the findings if it were an effect of Influenza-like-illness (ILI) caused by any respiratory infection (not solely influenza) operating via confounding by healthy-user effects and social determinants. Healthy users are more likely to be vaccinated and also less likely to acquire seasonal influenza making them potentially more at risk for pH1N1 due to the fact that they would be less likely to have temporary immunity. On the other spectrum, social deprivation has been shown to be related to a reduced uptake to seasonal influenza vaccination [8,9] as well as an increased risk of becoming ill due to respiratory infections including influenza [Lowcock EC et al. in press] [10]. We aimed to recreate the observed link between seasonal vaccine and pandemic H1N1 in a case control study assuming that the underlying distribution of individuals in social determinants and healthy user categories would have differential effects on both vaccine uptake and as a result in protective temporary immunity that could explain the observed positive association.

Methods

We defined a confounder as a third factor which is related to both exposure (seasonal influenza vaccination) and outcome (pandemic influenza), and accounts for some or all of the observed relationship between the two (Figure 1). We constructed stratified results of a hypothetical case control study of 1000 subjects with a study design ratio of cases to controls of 1:1 (i.e. 500 in each group). In order to investigate the role of two unmeasured confounders, we stratified the case control population by healthy users (yes or no) and social determinants (present or not). To construct the underlying pre-pandemic distribution we assumed the effect of social determinants is to make people both less likely to be vaccinated and more likely to get sick and tested for seasonal influenza and other respiratory infections (confounding that results in a bias in favour of the seasonal vaccine). In a standard 2 by 2 table (Figure 2) comparing seasonal influenza vaccination status and pH1N1 case/control status, this would move people from cell a to c because we would expect to have recruited more unvaccinated cases with social determinants. We used an effect size that would drop vaccination coverage among those with the social determinants from 40% to 20%, potentially doubling risk of influenza (Table 1) and assumed this social determinants effect to be present in 20% of the population (Lowcock EC et al. In Press). We assumed that healthy users are more likely to be vaccinated and less likely to get seasonal influenza (Figure 2). This confounding also results in a bias in favour of vaccine, and moves people from cell d to b in the 2 by 2 because we would expect to have recruited more healthy users. We used an effect size of an absolute increase by 10% in seasonal influenza vaccine coverage among healthy users and a prevalence of 32% in the population, estimated on the basis of this being around half of the population that remains after excluding the 30% reporting a chronic disease [11]. For simplicity, we assumed that healthy users and those with social determinants are mutually exclusive and that case and control distribution remains 1:1 overall. We assumed that non-influenza respiratory infection would have the same qualitative effect on temporary immunity as influenza, whereby higher rates of both influenza and non-influenza respiratory infection caused by social determinants would increase protection from subsequent pH1N1 and lower rates of seasonal and non-influenza respiratory infections would increase susceptibility of healthy users. We set the impact of both influenza and non-influenza respiratory infections on temporary immunity equivalent to a 10% change in the distribution of cases and controls within a stratum. Baseline vaccination coverage was taken to be 40% based on Ontario’s Universal Influenza Immunization Program (UIIP) [12]. We assumed that being a healthy user does not however directly reduce the risk of pH1N1 because this is a susceptible population and so the force of infection would be high in most age groups. We ignored the impact of pre-existing immunity in older age groups [13].

thumbnailFigure 1 . Effect of temporary immunity and biases associated with seasonal influenza vaccination.

thumbnailFigure 2 . A standard two-by-two table with a demonstration of the different effects of the healthy user effect and social determinants on the distribution of cases and controls and their vaccination status.

Table 1. Baseline parameter assumptions

The baseline assumptions used to create the pre-pandemic population are shown in Table 1. We set the seasonal vaccine vaccine effectiveness at approximately 60% and assumed it had no effect on the risk of acquiring pandemic H1N1 (i.e. odds ratio equal to 1). The odds ratio derived from the summary Table 2 is deliberately calculated incorrectly, such that the effect of confounding by healthy users and social determinants is ignored, and thereby demonstrates what would be observed if confounding were not taken into account. We then calculated the odds ratio correctly using the Mantel Haenszel method to show the impact of accounting for these confounding factors [14].

Table 2. Seasonal influenza vaccination and H1N1 infection stratified by healthy users and social determinants

We stratified the 500 cases and 500 controls based on the assumptions in Table 1 and re-constructed the vaccine effectiveness that was observed previously for seasonal influenza [3]. We populated the 2 by 2 tables between seasonal influenza vaccine and pandemic H1N1 influenza based on the hypothetical scenario that the unmeasured effects of healthy users and social determinants would influence both vaccine uptake and likelihood of acquiring temporary immunity through seasonal influenza infection and non-influenza respiratory infections prior to the pandemic.

Results

Using the baseline assumptions to re-create the post-pH1N1 wave 1 associations and assumptions about the prevalence of healthy users and those with social determinants, an unadjusted odds ratio of 1.3 (95% CI: 1.0 to 1.7) would result between seasonal influenza vaccine and pandemic infection. The two confounding factors each had their own independent influence on pH1N1 based on our assumptions such that healthy users were twice as likely to be vaccinated against seasonal influenza (OR = 2.0, 95% CI: 1.5 to 2.6) and four times more likely to test positive for pH1N1 (OR = 4.0, 95% CI: 3.1 - 5.3). Those with social determinants were 70% less likely to be vaccinated against seasonal influenza (OR = 0.31, 95% CI: 0.21 to 0.44) and 65% less likely to test positive for pH1N1 (OR = 0.35, 95% CI: (0.25 TO 0.49) due to cross-protected immunity. Stratum-specific odds ratios are equal to 1 due to the fact that we assumed no effect modification. After accounting for the unmeasured effects of being a healthy user and having social determinants using the Mantel Haenszel method, this association would be reduced from 1.3 to 1.0 with the final association being non-significant (95% CI: 0.8 to 1.3). Increasing the sample size to 10,000 did slightly reduce the confidence intervals (Unadjusted OR = 1.3 95% CI: 1.2 to 1.4) but did not change the overall finding. We ran a secondary analysis assuming various levels of co-occurrence between social determinants and healthy users but because the effects were opposing each other this did not significantly change the overall finding. Furthermore, these confounders are unlikely to co-occur so any influence would be expected to be minimal.

Discussion

The potential for unmeasured confounding exists in any observational design. Exploring the nature of this uncertainty is important to the interpretation of observational studies to assess vaccine effectiveness [15]. This study demonstrates a simple way to reveal the potential impact of unmeasured confounding that is related to temporary immunity on estimates of vaccine effectiveness using stratified tables. Overall we show that the presence of unmeasured confounder that is related to temporary immunity could possible bias the risk estimates away from the null and that this would result negatively for seasonal influenza (positive VE) and positively for pH1N1 (negative VE). The observed odds ratios are lower than what was observed in the studies by Skowronski et al. [1]; however, the direction of effect is consistent such that a protective effect for seasonal influenza and an increased risk for pandemic influenza may be observed. We have to acknowledge that this is an artificial, simplified and constructed scenario with a range of assumptions that are subject to uncertainty. Furthermore, it is possible that the baseline assumptions may differ from what was observed during the pandemic, but we believe them to be within a reasonable range of what is observed through a number of different data sources. This should be conceptualized as a thought experiment that illustrates the effect of confounding that is related to temporary immunity in a way that might be helpful for epidemiologists in the field.

Some unique circumstances during the 2009 pandemic in Canada may have affected the observations made, including the close timing of the first wave in relation to the end of the previous winter season of respiratory infections. Modelling has shown that this timing is critical [16]. It is also worth noting that winter regularly brings a mixture of different influenza and other respiratory viruses. If it is true that the activation of temporary immunity by one respiratory virus might affect susceptibility to others, then this effect may operate to a greater or lesser extent during every influenza season, and would also be likely to vary during any given season. Given the relationship between respiratory infections and vaccination, there is significant potential for this to be an important contributor to unexplained variation in observed vaccine effectiveness. Such variation includes apparent lack of concordance between influenza strain match and vaccine effectiveness. No conclusions can be drawn about the biology of temporary immunity from this study, but these findings support further immunological research into potential mechanisms.

If unmeasured confounding distorts observations of vaccine effectiveness this creates a huge challenge for influenza epidemiologists. The influenza vaccine can be confounded more so than other vaccine exposures due to the fact that the uptake is not universal in all populations. Influenza vaccine uptake will vary according to health care access, indications, occupations and underlying medical conditions, all of which can also influence the likelihood of acquiring influenza.

Confounding is most effectively addressed either through design or through measurement so that we can adjust for its effects during the analysis. It is much harder to design out confounding in observational studies compared to randomized controlled trials. For observational studies on vaccine effectiveness the best solution is to measure confounders and adjust for them in the analysis. This requires greater sample size as well as the ability to accurately measure confounders using feasible and reproducible methods. Other methods to address unmeasured confounding include sensitivity analyses [4,11] and simulation [12,17], which require complex approaches as well as good baseline data into assumptions of potential confounders that exist in the population.

This analysis is subject to baseline assumptions and furthermore did not consider joint or multiplicative effects; thus, may not reflect the situation during the 2009 pandemic. Nevertheless it demonstrates that failure to control for confounders that may bias the associations with the seasonal influenza vaccine (or the pandemic influenza vaccine) will affect the measures of associations. Furthermore these measures of associations can influence different respiratory outcomes (i.e. seasonal influenza versus pandemic influenza) differently.

Conclusions

Further research is needed into methods that can more completely measure social and behavioural confounders in influenza vaccine effectiveness studies and can be integrated easily into public health surveillance. Until this can be accomplished, questions will always remain about the validity of influenza vaccine effectiveness estimates derived from observational studies.

Competing interest

The authors declare that they have no competing interests.

Authors’ contributions

NSC carried out the initial analysis and wrote and edited the manuscript; LCR verified and carried out additional analysis, writing and editing of the manuscript. All authors read and approved the final manuscript.

References

  1. Skowronski DM, De Serres G, Crowcroft NS, Janjua NZ, Boulianne N, Hottes TS, et al.: Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.

    PLoS Med 2010, 7(4):e1000258. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  2. Janjua NZ, Skowronski DM, Hottes TS, et al.: Seasonal Influenza Vaccine and Increased Risk of Pandemic A/H1N1-Related Illness: First Detection of the Association in British Columbia, Canada.

    Clin Infect Dis 2010, 51(9):1017-1027. PubMed Abstract | Publisher Full Text OpenURL

  3. Baxter R, Lee J, Fireman B: Evidence of Bias in Studies of Influenza Vaccine Effectiveness in Elderly Patients.

    J Infect Dis 2010, 201(2):186-189. PubMed Abstract | Publisher Full Text OpenURL

  4. Hak E, Verheij TJM, Grobbee DE, Nichol KL, Hoes AW: Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications.

    J Epidemiol Community Health 2002, 56(12):951-955. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  5. Rosella LC, Groenwold RHH, Crowcroft NS: Assessing the impact of confounding (measured and unmeasured) in a case control study to examine the increased risk of pandemic A/H1N1 associated with receipt of the 2008-9 seasonal influenza vaccine.

    Vaccine OpenURL

  6. Kelly H, Barry S, Laurie K, Mercer G: Seasonal influenza vaccination and the risk of infection with pandemic influenza: a possible illustration of non-specific temporary immunity following infection.

    Euro Surveill 2010., 15(47)

    pii: 19722

    OpenURL

  7. Skowronski DM, Janjua NZ, De Serres G, Hottes TS, Dickinson JA, Crowcroft N, Kwindt TL, Tang P, Charest H, Fonseca K, Gubbay JB, Bastien N, Li Y, Petric M: Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009.

    BMJ 2011, 342:c7297. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  8. Damiani G, Federico B, Visca M, Agostini F, Ricciardi W: The impact of socioeconomic level on influenza vaccination among Italian adults and elderly: A cross-sectional study.

    Prev Med 2007, 45(5):373-379. PubMed Abstract | Publisher Full Text OpenURL

  9. Uddin M, Cherkowski GC, Liu G, Zhang J, Monto AS, Aiello AE: Demographic and socioeconomic determinants of influenza vaccination disparities among university students.

    J Epidemiol Community Health 2010, 64(9):808-813. PubMed Abstract | Publisher Full Text OpenURL

  10. Pawlinska-Chmara R, Wronka I: Assessment of the effect of socioeconomic factors on the prevalence of respiratory disorders in children.

    J Physiol Pharmacol 2007, 58:523-529. PubMed Abstract | Publisher Full Text OpenURL

  11. Ontario Health Quality Council press release on Chronic Disease in Ontario:

    Ontario Health Quality Council press release on Chronic Disease in Ontario. 2011.

    http://www.ohqc.ca/pdfs/final_press_release_march_26th_english.pdf webcite Accessed 29th September

    OpenURL

  12. Statistics Canada:

    Table 105-0501 - Health indicator profile, annual estimates, by age group and sex, Canada, provinces, territories, health regions and peer groups, occasional. CANSIM (database) [accessed:September 22, 2011]. 2011.

    http://www5.statcan.gc.ca/cansim/a01?lang=eng webcite.

    OpenURL

  13. Xing Z, Cardona CJ:

    Preexisting immunity to pandemic (H1N1) 2009 [letter]. Emerg Infect Dis [serial on the Internet]. 2009.

    http://wwwnc.cdc.gov/eid/article/15/11/09-0685.htm webcite.

    OpenURL

  14. Fleiss JL: Statistical Methods for rates and proportions. 2nd edition. New York: Wiley; 1981. OpenURL

  15. Groenwold RHH, Hoes AW, Nichol KL, Hak E: Quantifying the potential role of unmeasured confounders: the example of influenza vaccination.

    Int J Epidemiol 2008, 37(6):1422-1429. PubMed Abstract | Publisher Full Text OpenURL

  16. Mercer GN, Barry SI, Kelly H: Modelling the effect of seasonal influenza vaccination on the risk of pandemic influenza infection.

    BMC Public Health 2011, 11(Suppl 1):S11. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  17. Steenland K, Greenland S: Monte Carlo sensitivity analysis and Bayesian analysis of smoking as an unmeasured confounder in a study of silica and lung cancer.

    Am J Epidemiol 2004, 160(4):384-392. PubMed Abstract | Publisher Full Text OpenURL

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-2458/12/458/prepub